Consultation display
New psychoactive substances
- This consultation has completed. It ran from Thursday, 3 July 2014 to Friday, 17 October 2014
- View the background to this consultation
- View all current consultations
Response to the consultation
Evidence submitted in response to this Consultation
- LH 01 South Wales Police
PDF 159 KB View as HTML (2) 9 KB
- LH 01 South Wales Police - Annex A
PDF 1 MB
- LH 02 National Offender Management Service
PDF 285 KB View as HTML (4) 30 KB
- LH 03 The British Psychological Society
PDF 384 KB
- LH 04 Turning Point
PDF 272 KB View as HTML (6) 30 KB
- LH 05 The Police Federation of England and Wales.
PDF 231 KB
- LH 06 Welsh Heads of Trading Standards (WHoTS)
PDF 399 KB View as HTML (8) 27 KB
- LH 07 Drugstraining.com
PDF 183 KB View as HTML (9) 40 KB
- LH 08 WLGA
PDF 199 KB View as HTML (10) 42 KB
- LH 09 UKChemicalresearch
PDF 312 KB View as HTML (11) 24 KB
- LH 10 Royal College of Psychiatrists in Wales
PDF 248 KB View as HTML (12) 30 KB
- LH 11 Angelus Foundation
PDF 431 KB View as HTML (13) 29 KB
- LH 12 North Wales Police
PDF 8 MB
- LH 13 DrugScope
PDF 307 KB View as HTML (15) 18 KB
- LH 14 Abertawe Bro Morgannwg University Health Board
PDF 226 KB View as HTML (16) 9 KB
- LH 15 Aneurin Bevan University Health Board
PDF 632 KB View as HTML (17) 43 KB
- LH 16 Betsi Cadwaladr University Health Board
PDF 149 KB View as HTML (18) 17 KB
- LH 17 Public Health Wales
PDF 195 KB View as HTML (19) 51 KB
- LH 18 HM Inspectorate of Prisons
PDF 347 KB
- LH 19 TARIAN Regional Organised Crime Unit
PDF 572 KB
- LH 20 Hywel Dda University Health Board
PDF 289 KB
- LH 21 Welsh Ambulance Services NHS Trust
PDF 401 KB View as HTML (23) 103 KB
- LH 22 Gwent Police and Crime Commissioner
PDF 200 KB View as HTML (24) 30 KB
- Additional information
- LH AI 01 TICTAC
PDF 34 KB View as HTML (26) 9 KB
- LH AI 02 European Commission
PDF 129 KB View as HTML (27) 12 KB
- LH AI 03 Association of Chief Trading Standards Officers (ACTSO)
PDF 288 KB View as HTML (28) 23 KB
- LH AI 04 Welsh Government
PDF 158 KB View as HTML (29) 12 KB
- LH AI 05 PACE (Partners and Communities Engaging)
PDF 523 KB View as HTML (30) 133 KB
- LH AI 06 Government of Ireland
PDF 131 KB View as HTML (31) 16 KB
- LH AI 07 Public Health Wales
PDF 175 KB View as HTML (32) 13 KB
Purpose of the consultation
The National Assembly for Wales’ Health and Social Care Committee
undertook an inquiry into new psychoactive substances.
The Committee considered the
following areas as part of its inquiry:
- How
to raise awareness of the harms associated with the use of new
psychoactive substances among the public and those
working in the relevant public services.
- The
capacity of local services across Wales to raise awareness of – and deal
with the impact of – the harms associated with the use of new
psychoactive substances.
- The
effectiveness of data collection and reporting on the use of new
psychoactive substances in Wales and their effects.
- The
possible legislative approaches to tackling the issue of new
psychoactive substances, at both Welsh Government and
UK Government level.
- How
effectively a partnership approach to tackling the issue of new
psychoactive substances in Wales is being coordinated,
both within Wales and between the Welsh and UK Governments.
- International
evidence on approaches taken to new psychoactive substances in other countries.
To
note: New psychoactive substances (often referred to as “legal highs”) are
drugs which have been synthesised to mimic the effects of illegal drugs and
which are sought for intoxicant use. Because they are newly created, they are
not automatically controlled under drugs legislation (in the UK, the Misuse of
Drugs Act 1971). The term may also include substances of herbal origin (“herbal
highs”).
The consultation has now closed.
Supporting documents
Contact details
Should you wish to speak to someone regarding this consultation, please use the below contact details:
Health and Social Care Committee - Fourth Assembly
Welsh Parliament
Cardiff Bay
Cardiff
CF99 1SN
Email: Contact@senedd.wales
Telephone: 0300 200 6565